CRISPR and the Future of Cancer Treatments: Implications for Malaysian Medical Students

The emergence of CRISPR-Cas9 gene-editing technology has marked a transformative milestone in biomedical research, offering unprecedented potential to develop targeted therapies for a range of diseases, particularly cancer. This paper delves into the role of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) in advancing cancer treatment, with an emphasis on the fundamental mechanisms of the technology, its promise for more precise and effective therapies, and the challenges encountered in translating CRISPR from the laboratory to clinical settings. The technology’s ability to precisely target and modify genes has the potential to revolutionize cancer therapies, offering personalized treatments tailored to the genetic makeup of individual tumors. However, the clinical application of CRISPR faces significant hurdles, including concerns about off-target effects, ethical dilemmas surrounding germline editing, and the development of safe and efficient delivery mechanisms. In the context of Malaysia, this paper explores the relevance of CRISPR innovation within the medical and educational sectors. It highlights how Malaysian medical schools are incorporating gene-editing technologies into curricula to ensure future healthcare professionals are well-prepared to navigate the complexities of CRISPR applications. Moreover, the discussion expands to include the ethical, social, and legal implications of CRISPR technology.